Modulation of amyloid β-protein clearance and Alzheimer's disease susceptibility by the LDL receptor-related protein pathway

David E. Kang, Claus U. Pietrzik, Larry Baum, Nathalie Chevallier, David E. Merriam, Maria Z. Kounnas, Steven L. Wagner, Juan C Troncoso, Claudia H. Kawas, Robert Katzman, Edward H. Koo

Research output: Contribution to journalArticle

Abstract

Susceptibility to Alzheimer's disease (AD) is governed by multiple genetic factors. Remarkably, the LDL receptor-related protein (LRP) and its ligands, apoE and α2M, are all genetically associated with AD. In this study, we provide evidence for the involvement of the LRP pathway in amyloid deposition through sequestration and removal of soluble amyloid β-protein (Aβ). We demonstrate in vitro that LRP mediates the clearance of both Aβ40 and Aβ42 through a bona fide receptor-mediated uptake mechanism. In vivo, reduced LRP expression is associated with LRP genotypes and is correlated with enhanced soluble Aβ levels and amyloid deposition. Although LRP has been proposed to be a clearance pathway for Aβ, this work provides the first in vivo evidence that the LRP pathway may modulate Aβ deposition and AD susceptibility by regulating the removal of soluble Aβ.

Original languageEnglish (US)
Pages (from-to)1159-1166
Number of pages8
JournalJournal of Clinical Investigation
Volume106
Issue number9
StatePublished - 2000

Fingerprint

Low Density Lipoprotein Receptor-Related Protein-1
Amyloidogenic Proteins
Disease Susceptibility
Alzheimer Disease
Amyloid
Serum Amyloid A Protein
Apolipoproteins E
Genotype
Ligands

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Kang, D. E., Pietrzik, C. U., Baum, L., Chevallier, N., Merriam, D. E., Kounnas, M. Z., ... Koo, E. H. (2000). Modulation of amyloid β-protein clearance and Alzheimer's disease susceptibility by the LDL receptor-related protein pathway. Journal of Clinical Investigation, 106(9), 1159-1166.

Modulation of amyloid β-protein clearance and Alzheimer's disease susceptibility by the LDL receptor-related protein pathway. / Kang, David E.; Pietrzik, Claus U.; Baum, Larry; Chevallier, Nathalie; Merriam, David E.; Kounnas, Maria Z.; Wagner, Steven L.; Troncoso, Juan C; Kawas, Claudia H.; Katzman, Robert; Koo, Edward H.

In: Journal of Clinical Investigation, Vol. 106, No. 9, 2000, p. 1159-1166.

Research output: Contribution to journalArticle

Kang, DE, Pietrzik, CU, Baum, L, Chevallier, N, Merriam, DE, Kounnas, MZ, Wagner, SL, Troncoso, JC, Kawas, CH, Katzman, R & Koo, EH 2000, 'Modulation of amyloid β-protein clearance and Alzheimer's disease susceptibility by the LDL receptor-related protein pathway', Journal of Clinical Investigation, vol. 106, no. 9, pp. 1159-1166.
Kang, David E. ; Pietrzik, Claus U. ; Baum, Larry ; Chevallier, Nathalie ; Merriam, David E. ; Kounnas, Maria Z. ; Wagner, Steven L. ; Troncoso, Juan C ; Kawas, Claudia H. ; Katzman, Robert ; Koo, Edward H. / Modulation of amyloid β-protein clearance and Alzheimer's disease susceptibility by the LDL receptor-related protein pathway. In: Journal of Clinical Investigation. 2000 ; Vol. 106, No. 9. pp. 1159-1166.
@article{7e2ff6bbf04d4db49b30b1b914436b06,
title = "Modulation of amyloid β-protein clearance and Alzheimer's disease susceptibility by the LDL receptor-related protein pathway",
abstract = "Susceptibility to Alzheimer's disease (AD) is governed by multiple genetic factors. Remarkably, the LDL receptor-related protein (LRP) and its ligands, apoE and α2M, are all genetically associated with AD. In this study, we provide evidence for the involvement of the LRP pathway in amyloid deposition through sequestration and removal of soluble amyloid β-protein (Aβ). We demonstrate in vitro that LRP mediates the clearance of both Aβ40 and Aβ42 through a bona fide receptor-mediated uptake mechanism. In vivo, reduced LRP expression is associated with LRP genotypes and is correlated with enhanced soluble Aβ levels and amyloid deposition. Although LRP has been proposed to be a clearance pathway for Aβ, this work provides the first in vivo evidence that the LRP pathway may modulate Aβ deposition and AD susceptibility by regulating the removal of soluble Aβ.",
author = "Kang, {David E.} and Pietrzik, {Claus U.} and Larry Baum and Nathalie Chevallier and Merriam, {David E.} and Kounnas, {Maria Z.} and Wagner, {Steven L.} and Troncoso, {Juan C} and Kawas, {Claudia H.} and Robert Katzman and Koo, {Edward H.}",
year = "2000",
language = "English (US)",
volume = "106",
pages = "1159--1166",
journal = "Journal of Clinical Investigation",
issn = "0021-9738",
publisher = "The American Society for Clinical Investigation",
number = "9",

}

TY - JOUR

T1 - Modulation of amyloid β-protein clearance and Alzheimer's disease susceptibility by the LDL receptor-related protein pathway

AU - Kang, David E.

AU - Pietrzik, Claus U.

AU - Baum, Larry

AU - Chevallier, Nathalie

AU - Merriam, David E.

AU - Kounnas, Maria Z.

AU - Wagner, Steven L.

AU - Troncoso, Juan C

AU - Kawas, Claudia H.

AU - Katzman, Robert

AU - Koo, Edward H.

PY - 2000

Y1 - 2000

N2 - Susceptibility to Alzheimer's disease (AD) is governed by multiple genetic factors. Remarkably, the LDL receptor-related protein (LRP) and its ligands, apoE and α2M, are all genetically associated with AD. In this study, we provide evidence for the involvement of the LRP pathway in amyloid deposition through sequestration and removal of soluble amyloid β-protein (Aβ). We demonstrate in vitro that LRP mediates the clearance of both Aβ40 and Aβ42 through a bona fide receptor-mediated uptake mechanism. In vivo, reduced LRP expression is associated with LRP genotypes and is correlated with enhanced soluble Aβ levels and amyloid deposition. Although LRP has been proposed to be a clearance pathway for Aβ, this work provides the first in vivo evidence that the LRP pathway may modulate Aβ deposition and AD susceptibility by regulating the removal of soluble Aβ.

AB - Susceptibility to Alzheimer's disease (AD) is governed by multiple genetic factors. Remarkably, the LDL receptor-related protein (LRP) and its ligands, apoE and α2M, are all genetically associated with AD. In this study, we provide evidence for the involvement of the LRP pathway in amyloid deposition through sequestration and removal of soluble amyloid β-protein (Aβ). We demonstrate in vitro that LRP mediates the clearance of both Aβ40 and Aβ42 through a bona fide receptor-mediated uptake mechanism. In vivo, reduced LRP expression is associated with LRP genotypes and is correlated with enhanced soluble Aβ levels and amyloid deposition. Although LRP has been proposed to be a clearance pathway for Aβ, this work provides the first in vivo evidence that the LRP pathway may modulate Aβ deposition and AD susceptibility by regulating the removal of soluble Aβ.

UR - http://www.scopus.com/inward/record.url?scp=0033762062&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033762062&partnerID=8YFLogxK

M3 - Article

C2 - 11067868

AN - SCOPUS:0033762062

VL - 106

SP - 1159

EP - 1166

JO - Journal of Clinical Investigation

JF - Journal of Clinical Investigation

SN - 0021-9738

IS - 9

ER -